NCT06766214View on ClinicalTrials.gov

Attexis and tDCS for the Treatment of ADHD

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

June 30, 2026

Conditions
ADHD
Interventions
DEVICE

transcranial direct current stimulation

Simultaneous treatment with tDCS and online-based psychotherapy

DEVICE

sham transcranial direct current stimulation

Simultaneous treatment with sham-tDCS and online-based psychotherapy

Trial Locations (1)

93053

Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany, Regensburg

All Listed Sponsors
collaborator

Sooma Medical

UNKNOWN

collaborator

Gaia AG

INDUSTRY

lead

University of Regensburg

OTHER